0001209191-22-034919.txt : 20220607 0001209191-22-034919.hdr.sgml : 20220607 20220607200013 ACCESSION NUMBER: 0001209191-22-034919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220606 FILED AS OF DATE: 20220607 DATE AS OF CHANGE: 20220607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kropotova Alexandra CENTRAL INDEX KEY: 0001825323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 221002335 MAIL ADDRESS: STREET 1: RIVER OAKS TOWER STREET 2: 8800 HSC PARKWAY CITY: BYRAN STATE: TX ZIP: 77807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 BUSINESS PHONE: 605-679-6980 MAIL ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-06 0 0001833214 SAB Biotherapeutics, Inc. SABS 0001825323 Kropotova Alexandra 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 0 1 0 0 Chief Medical Officer Common Stock 2022-06-06 4 A 0 300000 0.00 A 300000 D Restricted Stock Unit ("RSU") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on June 6, 2023, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. /s/ Alexandra Kropotova 2022-06-07